High serum bone-specific alkaline phosphatase level after bortezomib-combined therapy in refractory multiple myeloma: possible role of bortezomib on osteoblast differentiation
Gespeichert in:
| Veröffentlicht in: | Leukemia 2005-06, Vol.19 (6), p.1102-1103 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1103 |
|---|---|
| container_issue | 6 |
| container_start_page | 1102 |
| container_title | Leukemia |
| container_volume | 19 |
| creator | Shimazaki, C Uchida, R Nakano, S Namura, K Fuchida, S-i Okano, A Okamoto, M Inaba, T |
| description | |
| doi_str_mv | 10.1038/sj.leu.2403758 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_journals_2645712955</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A188524938</galeid><sourcerecordid>A188524938</sourcerecordid><originalsourceid>FETCH-LOGICAL-c615t-59365fd6fbdb29817fe6381515e5704ff871d09bfb51813b0170d79fef4ef3293</originalsourceid><addsrcrecordid>eNp1klFrFDEQx4MotlZffZSg4Ntek91NNutbKWqFgi_6HJLdyW3OZLMmWeH8Un5Fc_bgKrQEEpj5zT_MzB-h15RsKGnEZdptHKybuiVNx8QTdE7bjleMMfoUnRMhuor3dXuGXqS0I-SQ5M_RGWWiIYSIc_Tnxm4nnCCuHuswQ5UWGKyxA1buh3J2BrxMIS2TyioBdvALHFYmQyx4zPA7eKurIXhd0BHnCaJa9tjOOIKJasgh7rFfXbaLA-z34IJXH_ASUrK6RGIoVzD3xHCYcUgZgnYqZTxaYyDCnK3KNswv0TOjXIJXx_cCff_08dv1TXX79fOX66vbauCU5Yr1DWdm5EaPuu4F7QzwRlBGGbCOtMaIjo6k10YzKmijCe3I2PUGTAumqfvmAr27011i-LlCynIX1jiXL2XNW9bRumesUG8fpWrCOKeNOEltlQNpZxNyGYy3aZBXVAhWt_0_avMAVc4I3g5lM8aW-H8F7-8VTKBcnlJw62FK6UHlIZapl7XIJVqv4l5SIg8mkmkni4nk0USl4M2xq1V7GE_40TUFuLwDUknNW4inth-R_AuFJNU-</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>220566138</pqid></control><display><type>article</type><title>High serum bone-specific alkaline phosphatase level after bortezomib-combined therapy in refractory multiple myeloma: possible role of bortezomib on osteoblast differentiation</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><source>Nature</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Shimazaki, C ; Uchida, R ; Nakano, S ; Namura, K ; Fuchida, S-i ; Okano, A ; Okamoto, M ; Inaba, T</creator><creatorcontrib>Shimazaki, C ; Uchida, R ; Nakano, S ; Namura, K ; Fuchida, S-i ; Okano, A ; Okamoto, M ; Inaba, T</creatorcontrib><identifier>ISSN: 0887-6924</identifier><identifier>EISSN: 1476-5551</identifier><identifier>DOI: 10.1038/sj.leu.2403758</identifier><identifier>PMID: 15830008</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>Alkaline phosphatase ; Alkaline Phosphatase - blood ; Antineoplastic Agents - administration & dosage ; Biomedical materials ; Boronic Acids - administration & dosage ; Bortezomib ; Cancer Research ; Cell Differentiation - drug effects ; correspondence ; Critical Care Medicine ; Hematology ; Humans ; Intensive ; Internal Medicine ; Male ; Medicine ; Medicine & Public Health ; Middle Aged ; Multiple myeloma ; Multiple Myeloma - complications ; Multiple Myeloma - drug therapy ; Oncology ; Osteoblastogenesis ; Osteoblasts - cytology ; Osteoblasts - drug effects ; Osteoblasts - enzymology ; Pyrazines - administration & dosage ; Spinal Fractures - complications</subject><ispartof>Leukemia, 2005-06, Vol.19 (6), p.1102-1103</ispartof><rights>Springer Nature Limited 2005</rights><rights>COPYRIGHT 2005 Nature Publishing Group</rights><rights>Copyright Nature Publishing Group Jun 2005</rights><rights>Nature Publishing Group 2005.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c615t-59365fd6fbdb29817fe6381515e5704ff871d09bfb51813b0170d79fef4ef3293</citedby><cites>FETCH-LOGICAL-c615t-59365fd6fbdb29817fe6381515e5704ff871d09bfb51813b0170d79fef4ef3293</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1038/sj.leu.2403758$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1038/sj.leu.2403758$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15830008$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shimazaki, C</creatorcontrib><creatorcontrib>Uchida, R</creatorcontrib><creatorcontrib>Nakano, S</creatorcontrib><creatorcontrib>Namura, K</creatorcontrib><creatorcontrib>Fuchida, S-i</creatorcontrib><creatorcontrib>Okano, A</creatorcontrib><creatorcontrib>Okamoto, M</creatorcontrib><creatorcontrib>Inaba, T</creatorcontrib><title>High serum bone-specific alkaline phosphatase level after bortezomib-combined therapy in refractory multiple myeloma: possible role of bortezomib on osteoblast differentiation</title><title>Leukemia</title><addtitle>Leukemia</addtitle><addtitle>Leukemia</addtitle><subject>Alkaline phosphatase</subject><subject>Alkaline Phosphatase - blood</subject><subject>Antineoplastic Agents - administration & dosage</subject><subject>Biomedical materials</subject><subject>Boronic Acids - administration & dosage</subject><subject>Bortezomib</subject><subject>Cancer Research</subject><subject>Cell Differentiation - drug effects</subject><subject>correspondence</subject><subject>Critical Care Medicine</subject><subject>Hematology</subject><subject>Humans</subject><subject>Intensive</subject><subject>Internal Medicine</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Middle Aged</subject><subject>Multiple myeloma</subject><subject>Multiple Myeloma - complications</subject><subject>Multiple Myeloma - drug therapy</subject><subject>Oncology</subject><subject>Osteoblastogenesis</subject><subject>Osteoblasts - cytology</subject><subject>Osteoblasts - drug effects</subject><subject>Osteoblasts - enzymology</subject><subject>Pyrazines - administration & dosage</subject><subject>Spinal Fractures - complications</subject><issn>0887-6924</issn><issn>1476-5551</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp1klFrFDEQx4MotlZffZSg4Ntek91NNutbKWqFgi_6HJLdyW3OZLMmWeH8Un5Fc_bgKrQEEpj5zT_MzB-h15RsKGnEZdptHKybuiVNx8QTdE7bjleMMfoUnRMhuor3dXuGXqS0I-SQ5M_RGWWiIYSIc_Tnxm4nnCCuHuswQ5UWGKyxA1buh3J2BrxMIS2TyioBdvALHFYmQyx4zPA7eKurIXhd0BHnCaJa9tjOOIKJasgh7rFfXbaLA-z34IJXH_ASUrK6RGIoVzD3xHCYcUgZgnYqZTxaYyDCnK3KNswv0TOjXIJXx_cCff_08dv1TXX79fOX66vbauCU5Yr1DWdm5EaPuu4F7QzwRlBGGbCOtMaIjo6k10YzKmijCe3I2PUGTAumqfvmAr27011i-LlCynIX1jiXL2XNW9bRumesUG8fpWrCOKeNOEltlQNpZxNyGYy3aZBXVAhWt_0_avMAVc4I3g5lM8aW-H8F7-8VTKBcnlJw62FK6UHlIZapl7XIJVqv4l5SIg8mkmkni4nk0USl4M2xq1V7GE_40TUFuLwDUknNW4inth-R_AuFJNU-</recordid><startdate>20050601</startdate><enddate>20050601</enddate><creator>Shimazaki, C</creator><creator>Uchida, R</creator><creator>Nakano, S</creator><creator>Namura, K</creator><creator>Fuchida, S-i</creator><creator>Okano, A</creator><creator>Okamoto, M</creator><creator>Inaba, T</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7T5</scope><scope>7T7</scope><scope>7TM</scope><scope>7TO</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PJZUB</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQEST</scope><scope>PQGLB</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20050601</creationdate><title>High serum bone-specific alkaline phosphatase level after bortezomib-combined therapy in refractory multiple myeloma: possible role of bortezomib on osteoblast differentiation</title><author>Shimazaki, C ; Uchida, R ; Nakano, S ; Namura, K ; Fuchida, S-i ; Okano, A ; Okamoto, M ; Inaba, T</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c615t-59365fd6fbdb29817fe6381515e5704ff871d09bfb51813b0170d79fef4ef3293</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Alkaline phosphatase</topic><topic>Alkaline Phosphatase - blood</topic><topic>Antineoplastic Agents - administration & dosage</topic><topic>Biomedical materials</topic><topic>Boronic Acids - administration & dosage</topic><topic>Bortezomib</topic><topic>Cancer Research</topic><topic>Cell Differentiation - drug effects</topic><topic>correspondence</topic><topic>Critical Care Medicine</topic><topic>Hematology</topic><topic>Humans</topic><topic>Intensive</topic><topic>Internal Medicine</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Middle Aged</topic><topic>Multiple myeloma</topic><topic>Multiple Myeloma - complications</topic><topic>Multiple Myeloma - drug therapy</topic><topic>Oncology</topic><topic>Osteoblastogenesis</topic><topic>Osteoblasts - cytology</topic><topic>Osteoblasts - drug effects</topic><topic>Osteoblasts - enzymology</topic><topic>Pyrazines - administration & dosage</topic><topic>Spinal Fractures - complications</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shimazaki, C</creatorcontrib><creatorcontrib>Uchida, R</creatorcontrib><creatorcontrib>Nakano, S</creatorcontrib><creatorcontrib>Namura, K</creatorcontrib><creatorcontrib>Fuchida, S-i</creatorcontrib><creatorcontrib>Okano, A</creatorcontrib><creatorcontrib>Okamoto, M</creatorcontrib><creatorcontrib>Inaba, T</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nursing & Allied Health Database</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>ProQuest Health & Medical Research Collection</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health & Nursing</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Applied & Life Sciences</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Leukemia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shimazaki, C</au><au>Uchida, R</au><au>Nakano, S</au><au>Namura, K</au><au>Fuchida, S-i</au><au>Okano, A</au><au>Okamoto, M</au><au>Inaba, T</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>High serum bone-specific alkaline phosphatase level after bortezomib-combined therapy in refractory multiple myeloma: possible role of bortezomib on osteoblast differentiation</atitle><jtitle>Leukemia</jtitle><stitle>Leukemia</stitle><addtitle>Leukemia</addtitle><date>2005-06-01</date><risdate>2005</risdate><volume>19</volume><issue>6</issue><spage>1102</spage><epage>1103</epage><pages>1102-1103</pages><issn>0887-6924</issn><eissn>1476-5551</eissn><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>15830008</pmid><doi>10.1038/sj.leu.2403758</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0887-6924 |
| ispartof | Leukemia, 2005-06, Vol.19 (6), p.1102-1103 |
| issn | 0887-6924 1476-5551 |
| language | eng |
| recordid | cdi_proquest_journals_2645712955 |
| source | MEDLINE; Springer Nature - Complete Springer Journals; Nature; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
| subjects | Alkaline phosphatase Alkaline Phosphatase - blood Antineoplastic Agents - administration & dosage Biomedical materials Boronic Acids - administration & dosage Bortezomib Cancer Research Cell Differentiation - drug effects correspondence Critical Care Medicine Hematology Humans Intensive Internal Medicine Male Medicine Medicine & Public Health Middle Aged Multiple myeloma Multiple Myeloma - complications Multiple Myeloma - drug therapy Oncology Osteoblastogenesis Osteoblasts - cytology Osteoblasts - drug effects Osteoblasts - enzymology Pyrazines - administration & dosage Spinal Fractures - complications |
| title | High serum bone-specific alkaline phosphatase level after bortezomib-combined therapy in refractory multiple myeloma: possible role of bortezomib on osteoblast differentiation |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T18%3A32%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=High%20serum%20bone-specific%20alkaline%20phosphatase%20level%20after%20bortezomib-combined%20therapy%20in%20refractory%20multiple%20myeloma:%20possible%20role%20of%20bortezomib%20on%20osteoblast%20differentiation&rft.jtitle=Leukemia&rft.au=Shimazaki,%20C&rft.date=2005-06-01&rft.volume=19&rft.issue=6&rft.spage=1102&rft.epage=1103&rft.pages=1102-1103&rft.issn=0887-6924&rft.eissn=1476-5551&rft_id=info:doi/10.1038/sj.leu.2403758&rft_dat=%3Cgale_proqu%3EA188524938%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=220566138&rft_id=info:pmid/15830008&rft_galeid=A188524938&rfr_iscdi=true |